ANPI Angiotech Pharmaceuticals - Common Shares (MM)

Fourth Quarter 2007 Financial Results VANCOUVER, Jan. 22 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), a global specialty pharmaceutical and medical device company, will host a conference call discussing its financial results for the fourth quarter and year ended December 31, 2007. Thursday, February 14, 2008 at 11:00 AM ET (8:00 AM Pacific, 9:00 AM Mountain, 10:00 AM Central) Dial information is as follows: North America (toll-free): (866) 510-0711 International: (617) 597-5379 Enter passcode: 91184096 A live webcast will be available to all interested parties through Angiotech's website at http://www.angiotech.com/ in the Investor Relations section. A press release announcing Angiotech's financial results will be issued prior to the conference call at approximately 8:00 AM ET (5:00 AM Pacific, 6:00 AM Mountain, 7:00 AM Central). A replay archive of the conference call will be available until February 21, 2008. Replay information is as follows: North America: (888) 286-8010 International: (617) 801-6888 Enter passcode: 85112963 About Angiotech Pharmaceuticals Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ:ANPINASDAQ:TSXNASDAQ:ANP) please visit our website at http://www.angiotech.com/. CONTACT: Jodi Regts, Senior Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930, ; Deirdre Neary, Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 222-7056, DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Jodi Regts, Senior Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930, ; Deirdre Neary, Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 222-7056,

Copyright